Chartis Precision Catheter— 510(k) K222340

Name: FDA 510(k) clearance K222340
Creator: U.S. Food and Drug Administration
Published: 2022-12-01

Substantially Equivalent

Pulmonx Corporation

FDA 510(k) clearance K222340 for Chartis Precision Catheter, Substantially Equivalent on 2022-12-01. Applicant: Pulmonx Corporation. Device class: 2.

Clearance details

Applicant: Pulmonx Corporation
Product code: Code CBI
Device class: Class 2
Regulation: 21 CFR 868.5740
Advisory panel: Anesthesiology
Date received: 2022-08-03
Decision date: 2022-12-01
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Redwood City, CA, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code CBI

view all

K251950 — Endobronchial Blocker Tube (12 models)2026-03-20
K253096 — Chartis Precision Catheter2026-02-13
K232529 — Disposable Double Lumen Endobronchial Tube2024-05-13
K232580 — Disposable Endobronchial Blocker Tube2023-12-14
K201026 — sOLVe Tube2021-08-10

More clearances from Pulmonx Corporation

view all

K212494 — Lung Image Analysis2021-09-02
K180011 — Pulmonx Chartis Tablet Console2018-07-13

Adverse events under product code CBI

product code CBI

Death: 4
Malfunction: 594
Total: 598

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.